International Congress Amsterdam 2015

Saturday, 26.09.2015 Sunday, 27.09.2015 Monday, 28.09.2015 Tuesday, 29.09.2015 Wednesday, 30.09.2015		Sponsored symposia: Evening Symposium organised by Novartis Pharma AG: "IgE-mediated asthma: New revelations and future insights" Evening Symposium organised by Boehringer Ingelheim International GmbH: "The challenge of treating uncontrolled asthma on Step 3 and higher: Comparing options" Industry early morning symposium organised by Novartis Pharma AG: "Multidisciplinary approaches in the personalized care of the ALK + NSCLC patient"

Citations should be made in the following way: Authors. Title. Eur Respir J 2015; 46: Suppl. 59, abstract number.

PG17 Lung fibrosis and sarcoidosis

Postgraduate Course
Chairs: Joachim Muller-Quernheim (Freiburg, Germany), Venerino Poletti (Forli, Italy)
Aims: To describe the different diagnostic approaches and treatment modalities in adult and paediatric patients with interstitial lung diseases.
Target audience: Paediatric and adult pulmonologists, epidemiologists, health professionals, public health physicians, and scientists interested in the aetiology and prevention of lung disease.

Educational Material

Handout PG17
Open

Reading list PG17
Open

How to access educational materials from mobile devices

Download all media

The pathomechanism of lung fibrosis and sarcoidosis Manuela Funke-Chambour (Bern, Switzerland)
The diagnostic and therapeutic standard Katerina Antoniou (Heraklion, Greece)
Chronic interstitial lung in children: diagnosis and treatment Annick Clement (Paris, France)
Lung transplantation: the pros and cons Geert Verleden (Leuven, Belgium)